Review: Epigenetic mechanisms in ocular disease

Molecular Vision

Volumn 19, Issue , 2013, Pages 665-674

  He, Shikun ^a,b   Li, Xiaohua ^c   Chan, Nymph ^a   Hinton, David R ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

^c Henan Eye Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; BUTYRIC ACID; CLUSTERIN; COLLAGEN TYPE 1; CYTOCHROME P450; DNA; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; UNTRANSLATED RNA; VALPROIC ACID; ZEBULARINE;

AMBLYOPIA; CATARACT; CELL DIFFERENTIATION; CELL RENEWAL; CHROMATIN STRUCTURE; CORNEA DYSTROPHY; DEACETYLATION; DIABETIC RETINOPATHY; DNA METHYLATION; DRUG METABOLISM; EPIGENETICS; EYE CANCER; EYE DISEASE; GENETIC REGULATION; GLAUCOMA; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN GENOME PROJECT; KERATITIS; MEDICAL RESEARCH; MYOPIA; NONHUMAN; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; RETINOBLASTOMA; REVIEW; STEM CELL; UVEA MELANOMA; UVEITIS; VITREORETINOPATHY;

ANIMALS; EPIGENESIS, GENETIC; EYE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84875412672     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Mazzio EA, Soliman KF. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics 2012; 7:119-130. [PMID: 22395460].
2. Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity (Edinb) 2010; 105:4-13. [PMID: 20461105].
3. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 2012; 13:528-41. [PMID: 22814587].
4. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057-68. [PMID: 20944598].
5. Webster AL, Yan MS, Marsden PA. Epigenetics and cardiovascular disease. Can J Cardiol 2013; 29:46-57. [PMID: 23261320].
6. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, Del Guerra S, Masini M, Bugliani M, Marchetti P, Cnop M, Eizirik DL, Fuks F. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J 2012; 31:1405-26. [PMID: 22293752].
7. Qureshi IA, Mehler ME. Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep 2011; 11:464-73. [PMID: 21671162].
8. Saito Y, Saito H. MicroRNAs in cancers and neurodegenerative disorders. Front Genet 2012; 3:194-Epub 2012 Sept 26[PMID: 23056009].
9. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12-27. [PMID: 22770212].
10. Smith ZD, Chan MM, Mikkelsen TS, Gu H, Gnirke A, Regev A, Meissner A. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 2012; 484:339-44. [PMID: 22456710].
11. Brunmeir R, Lagger S, Seiser C. Histone deacetylases HDAC1/HDAC2 -controlled embryonic development and cell differentiation. Int J Dev Biol 2009; 53:275-89. [PMID: 19412887].
12. Huber LC, Stanczyk J, Jüngel A, Gay S. Epigenetics in inflammatory rheumatic diseases. Arthritis Rheum 2007; 56:3523-31. [PMID: 17968922].
13. Ospelt C, Reedquist KA, Gay S, Tak P. Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmun Rev 2011; 10:519-24. [PMID: 21497675].
14. Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res 2011; 90:9-17. [PMID: 21178119].
15. Rodríguez-Rodero S, Fernández-Morera JL, Fernandez AF, Menéndez-Torre E, Fraga MF. Epigenetic regulation of aging. Discov Med 2010; 10:225-33. [PMID: 20875344].
16. Calvanese V, Fraga MF. Epigenetics of embryonic stem cells. Adv Exp Med Biol 2012; 741:231-53. [PMID: 22457114].
17. Fernández-Morera JL, Calvanese V, Rodríguez-Rodero S, Menéndez-Torre E, Fraga MF. Epigenetic regulation of the immune system in health and disease. Tissue Antigens 2010; 76:431-9. [PMID: 21058938].
18. Buysschaert I, Schmidt T, Roncal C, Carmeliet P, Lambrechts D. Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J Cell Mol Med 2008; 12:2533-51. [PMID: 19210754].
19. Raffoux E, Cras A, Recher C, Boëlle PY, de Labarthe A, Turlure P, Marolleau JP, Reman O, Gardin C, Victor M, Maury S, Rousselot P, Malfuson JV, Maarek O, Daniel MT, Fenaux P, Degos L, Chomienne C, Chevret S, Dombret H. Phase 2 clinical trials of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome. Oncotarget 2010; 1:34-42. [PMID: 21293051].
20. Wagner JM, Hackanson B, Lübbert M, Jung M. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 2010; 1:117-36. [PMID: 21258646].
21. Kriaucionis S, Heintz N. The Nuclear DNA Base 5-Hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929-30. [PMID: 19372393].
22. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5. [PMID: 19372391].
23. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011; 333:1303-7. [PMID: 21817016].
24. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011; 333:1300-3. [PMID: 21778364].
25. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92. [PMID: 22641018].
26. Cosgrove MS, Boeke JD, Wolberger C. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol 2004; 11:1037-43. [PMID: 15523479].
27. Barneda-Zahonero B, Parra M. Histone deacetylases and cancer. Mol Oncol 2012; 6:579-89. [PMID: 22963873].
28. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012; 111:1349-62. [PMID: 23104877].
29. Lee D, Shin C. MicroRNA-target interactions: new insights from genome-wide approaches. Ann N Y Acad Sci 2012; 1271:118-28. [PMID: 23050973].
30. Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012; 9:850-9. [PMID: 22699556].
31. Bell JT, Spector TD. A twin approach to unraveling epigenetics. Trends Genet 2011; 27:116-25. [PMID: 21257220].
32. Dunham I. The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489:57-74. [PMID: 22955616].
33. Zhu H, Shan L, Schiller P, Mai A, Peng T. Histone deacetylase-3 activation promotes tumor necrosis factor-(TNF) expression in cardiomyocytes during lipopolysaccharide stimulation. J Biol Chem 2010; 285:9429-36. [PMID: 20097764].
34. Hamon MA, Cossart P. Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 2008; 4:100-9. [PMID: 18692770].
35. Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta 2010; 1799:246-56.
36. Rao RC, Chen DF, Miller JW. An epigenetic approach toward understanding ocular α-herpesvirus pathogenesis and treatment. Int Ophthalmol Clin 2011; 51:117-33. [PMID: 21897145].
37. Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM, Miller CS. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript (LAT)-independent manner in neuronal cells. J Neurovirol 2005; 11:306-17. [PMID: 16036811].
38. Silingardi D, Scali M, Belluomini G, Pizzorusso T. Epigenetic treatments of adult rats promote recovery from visual acuity deficits induced by long-term monocular deprivation. Eur J Neurosci 2010; 31:2185-92. [PMID: 20550570].
39. Zhou X, Ji F, An J, Zhao F, Shi F, Huang F, Li Y, Jiao S, Yan D, Chen X, Chen J, Qu J. Experimental murine myopia induces collagen type Iα1 (COL1A1) DNA methylation and altered COL1A1 messenger RNA expression in sclera. Mol Vis 2012; 18:1312-24. [PMID: 22690110].
40. Negahban K, Chern K. Cataracts associated with systemice disorders and syndromes. Curr Opin Ophthalmol 2002; 13:419-22. [PMID: 12441847].
41. He S, Pirity MK, Wang WL, Wolf L, Chauhan BK, Cveklova K, Tamm ER, Ashery-Padan R, Metzger D, Nakai A, Chambon P, Zavadil J, Cvekl A. Chromatin remodeling enzyme Brg1 is required for mouse lens fiber cell terminal differentiation and its denucleation. Epigenetics Chromatin 2010; 3:21[PMID: 21118511].
42. Zhou P, Lu Y, Sun XH. Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2. Mol Vis 2011; 17:2717-23. [PMID: 22065925].
43. Chen LJ, Tam PO, Leung DY, Fan AH, Zhang M, Tham CC, Chiang SW, Fan BJ, Wang N, Pang CP. SNP rs1533428 at 2p16.3 as a marker for late-onset primary open-angle glaucoma. Mol Vis 2012; 18:1629-39. [PMID: 22773901].
44. Pelzel HR, Schlamp CL, Nickells RW. Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci 2010; 11:62[PMID: 20504333].
45. Pelzel HR, Schlamp CL, Waclawski M, Shaw MK, Nickells RW. Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Invest Ophthalmol Vis Sci 2012; 53:1428-35. [PMID: 22297488].
46. Biermann J, Grieshaber P, Goebel U, Martin G, Thanos S, Di Giovanni S, Lagrèze WA. Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci 2010; 51:526-34. [PMID: 19628741].
47. Jünemann A, Lenz B, Reulbach U. Schlötzer-Schrehardt, Rejdak R, Kornhuber J, Kruse F, Bleich S. Genomic (epigenetic) DNA methylation in patients with open-angle glaucoma. Acta Ophthalmol (Copenh) 2009; 87:s244-.
48. Saika S, Yamanaka O, Nishikawa-Ishida I, Kitano A, Flanders KC, Okada Y, Ohnishi Y, Nakajima Y, Ikeda K. Effect of Smad7 gene overexpression on transforming growth factor-β-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model. Arch Ophthalmol 2007; 125:647-54. [PMID: 17502504].
49. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010; 138:705-14. [PMID: 19843474].
50. Pang M, Zhuang S. Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther 2010; 335:266-72. [PMID: 20719940].
51. Catania A, Iavarone C, Carlomagno SM, Chiariello M. Selective transcription and cellular proliferation induced by PDGF require histone deacetylase activity. Biochem Biophys Res Commun 2006; 343:544-54. [PMID: 16554031].
52. Sahni JN, Angi M, Irigoyen C, Semeraro F, Romano MR, Parmeggiani F. Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy. Curr Genomics 2011; 12:276-84. [PMID: 22131873].
53. Sancho-Pelluz J, Alavi MV, Sahaboglu A, Kustermann S, Farinelli P, Azadi S, van Veen T, Romero FJ, Paquet-Durand F, Ekström P. Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse. Cell Death Dis 2010; 1:e24[PMID: 21364632].
54. Damiani D, Alexander JJ, O'Rourke JR, McManus M, Jadhav AP, Cepko CL, Hauswirth WW, Harfe BD, Strettoi E. Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina. J Neurosci 2008; 28:4878-87. [PMID: 18463241].
55. Loscher CJ, Hokamp K, Kenna PF, Ivens AC, Humphries P, Palfi A, Farrar GJ. Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol 2007; 8:R248[PMID: 18034880].
56. Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 2011; 95:89-93. [PMID: 20647559].
57. Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010; 299:F14-25. [PMID: 20462972].
58. Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab 2010; 298:E127-37. [PMID: 19903865].
59. Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 2010; 110:1306-13. [PMID: 20564224].
60. Wu JH, Gao Y, Ren AJ, Zhao SH, Zhong M, Peng YJ, Shen W, Jing M, Liu L. Altered miRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic Res 2012; 47:195-201. [PMID: 22156553].
61. Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2011; 52:4402-9. [PMID: 21498619].
62. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011; 60:1314-23. [PMID: 21357793].
63. Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron 2012; 75:26-39. [PMID: 22794258].
64. Hjelmeland LM. Dark matters in AMD genetics: epigenetics and stochasticity. Invest Ophthalmol Vis Sci 2011; 52:1622-31. [PMID: 21429863].
65. Liu MM, Chan CC, Tuo J. Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 2012; 6:13[PMID: 23244519].
66. Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). Ageing Res Rev 2009; 8:349-58. [PMID: 19589398].
67. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001; 7:437-43. [PMID: 11283670].
68. Kato H, Tamamizu-Kato S, Shibasaki F. Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J Biol Chem 2004; 279:41966-74. [PMID: 15280364].
69. Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA 2008; 105:7738-43. [PMID: 18509061].
70. Perez-Perri JI, Acevedo JM, Wappner P. Epigenetics: new questions on the response to hypoxia Int J Mol Sci 2011; 12:4705-21. [PMID: 21845106].
71. Crosson CE, Mani SK, Husain S, Alsarraf O, Menick DR. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci 2010; 51:3639-45. [PMID: 20164449].
72. Sivamurthy N, Stone DH, LoGerfo FW, Quist WC. Apolipoprotein J inhibits the migration and adhesion of endothelial cells. Surgery 2001; 130:204-9. [PMID: 11490350].
73. Jackson JK, Gleave ME, Gleave J, Burt HM. The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis 2005; 8:229-38. [PMID: 16308731].
74. Suuronen T, Nuutinen T, Ryhänen T, Kaarniranta K, Salminen A. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun 2007; 357:397-401. [PMID: 17420006].
75. Hunter A, Spechler PA, Cwanger A, Song Y, Zhang Z, Ying GS, Hunter AK, Dezoeten E, Dunaief JL. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci 2012; 53:2089-105. [PMID: 22410570].
76. Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen HN, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris FL 3rd, Chew EY, McCoy JP, Blum E, Francis PJ, Klein ML, Guymer RH, Baird PN, Chan CC, Nussenblatt RB. Hypomethylation of the IL-17RC promoter associates with age-related macular degeneration. Cell Rep. 2012; 2:1151-8. [PMID: 23177625].
77. Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noël A, Martial JA, Struman I. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS ONE 2011; 6:e16979[PMID: 21347332].
78. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA. MicroRNAs regulate ocular neovascularization. Mol Ther 2008; 16:1208-16. [PMID: 18500251].
79. Lin H, Qian J, Castillo AC, Long B, Keyes KT, Chen G, Ye Y. Effects of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2011; 52:6308-14. [PMID: 21693609].
80. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun 2010; 402:390-5. [PMID: 20950585].
81. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target complement factor H (CFH) regulating in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 2012; 3:105-16. [PMID: 22509485].
82. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG, Kleinman ME, Ponicsan SL, Hauswirth WW, Chiodo VA, Karikó K, Yoo JW, Lee DK, Hadziahmetovic M, Song Y, Misra S, Chaudhuri G, Buaas FW, Braun RE, Hinton DR, Zhang Q, Grossniklaus HE, Provis JM, Madigan MC, Milam AH, Justice NL, Albuquerque RJ, Blandford AD, Bogdanovich S, Hirano Y, Witta J, Fuchs E, Littman DR, Ambati BK, Rudin CM, Chong MM, Provost P, Kugel JF, Goodrich JA, Dunaief JL, Baffi JZ, Ambati J. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011; 471:325-30. [PMID: 21297615].
83. Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, Shurtleff S, Mullighan C, Pounds S, Mukatira S, Gupta P, Neale G, Zhao D, Lu C, Fulton RS, Fulton LL, Hong X, Dooling DJ, Ochoa K, Naeve C, Dyson NJ, Mardis ER, Bahrami A, Ellison D, Wilson RK, Downing JR, Dyer MA. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 2012; 481:329-34. [PMID: 22237022].
84. Liu R, Gao L, Lu GX, Tang LS, Zhu XH, Wang J. Methylation status of RASSF1A and DAPK promoter in retinoblastoma. Zhonghua Yan Ke Za Zhi 2009; 45:631-5. [PMID: 19957692].
85. Dratviman-Storobinsky O, Cohen Y, Frenkel S, Merhavi-Shoham E, Dadon Bar El S, Binkovsky N, Pe'er JJ, Goldenberg-Cohen N. The role of RASSF1A in uveal melanoma. Invest Ophthalmol Vis Sci 2012; Epub ahead of print[PMID: 22447862].
86. Calipel A, Abonnet V, Nicole O, Mascarelli F, Coupland SE, Damato B, Mouriaux F. Status of RASSF1A in uveal melanocytes and melanoma cells. Mol Cancer Res 2011; 9:1187-98. [PMID: 21788308].
87. Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N. Promoter methylation status of multiple genes in uveal melanoma. Invest Ophthalmol Vis Sci 2007; 48:4403-6. [PMID: 17898258].
88. Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA. Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci 2007; 48:486-90. [PMID: 17251440].
89. Moulin AP, Clément G, Bosman FT, Zografos L, Benhattar J. Methylation of CpG island promoters in uveal melanoma. Br J Ophthalmol 2008; 92:281-5. [PMID: 18211945].
90. Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Invest Ophthalmol Vis Sci 2003; 44:2390-8. [PMID: 12766035].
91. Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res 2012; 18:408-16. [PMID: 22038994].
92. Olynik BM, Rastegar M. The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front Genet 2012; 3:81-[PMID: 22629283].
93. Farthing CR, Ficz G, Ng RK, Chan C-F, Andrews S, Dean W, Hemberger M, Reik W. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet 2008; 4:e1000116[PMID: 18584034].
94. Shen Y, Chow J, Wang Z, Fan G. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 2006; 15:2623-35. [PMID: 16870691].
95. Petkova TD, Seigel GM, Otteson DC. A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina. Vision Res 2011; 51:260-8. [PMID: 20875442].
96. Peng CH, Chang YL, Kao CL, Tseng LM, Wu CC, Chen YC, Tsai CY, Woung LC, Liu JH, Chiou SH, Chen SJ. SirT1-a sensor for monitoring self-renewal and aging process in retinal stem cells. Sensors (Basel) 2010; 10:6172-94. [PMID: 22219708].
97. Lee SI, Lee BR, Hwang YS, Lee HC, Rengaraj D, Song G, Park TS, Han JY. MicroRNA-mediated posttranscriptional regulation is required for maintaining undifferentiated properties of blastoderm and primordial germ cells in chickens. Proc Natl Acad Sci USA 2011; 108:10426-31. [PMID: 21670268].
98. Glubb DM, Innocenti F. Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters. Wiley Interdiscip Rev Syst Biol Med 2011; 3:299-313. [PMID: 20865777].
99. Baer-Dubowska W, Majchrzak-Celińska A, Cichocki M. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs. Pharmacol Rep 2011; 63:293-304. [PMID: 21602587].
100. Tamási V, Monostory K, Prough RA, Falus A. Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s. Cell Mol Life Sci 2011; 68:1131-46. [PMID: 21184128].
101. Saied MH, Marzec J, Khalid S, Smith P, Down TA, Rakyan VK, Molloy G, Raghavan M, Debernardi S, Young BD. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. PLoS ONE 2012; 7:e33213[PMID: 22479372].
102. Feinberg AP. Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nat Biotechnol 2010; 28:1049-52. [PMID: 20944596].